CytomX Therapeutics, Inc. (CTMX): Price and Financial Metrics

CTMX POWR Grades

• Growth is the dimension where CTMX ranks best; there it ranks ahead of 95.93% of US stocks.
• The strongest trend for CTMX is in Quality, which has been heading down over the past 177 days.
• CTMX's current lowest rank is in the Momentum metric (where it is better than 4.01% of US stocks).

CTMX Stock Summary

• CYTOMX THERAPEUTICS INC's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than merely 4.88% of US listed stocks.
• CTMX's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of just 4.3% of US stocks.
• With a year-over-year growth in debt of -29.61%, CYTOMX THERAPEUTICS INC's debt growth rate surpasses only 11.25% of about US stocks.
• Stocks that are quantitatively similar to CTMX, based on their financial statements, market capitalization, and price volatility, are CRDF, HYLN, DBVT, VTGN, and PULM.
• Visit CTMX's SEC page to see the company's official filings. To visit the company's web site, go to www.cytomx.com.

CTMX Valuation Summary

• CTMX's EV/EBIT ratio is -0.7; this is 107.11% lower than that of the median Healthcare stock.
• Over the past 98 months, CTMX's price/sales ratio has gone down 60.

Below are key valuation metrics over time for CTMX.

CTMX Growth Metrics

The 3 year cash and equivalents growth rate now stands at -14.07%.
• Its 3 year revenue growth rate is now at -5.43%.
• The 3 year net cashflow from operations growth rate now stands at -30.48%.

CTMX's revenue has moved up $5,523,000 over the prior 15 months.

The table below shows CTMX's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	71.943	-140.586	-97.593
2022-06-30	72.615	-136.442	-96.881
2022-03-31	70.738	-130.404	-91.94
2021-12-31	69.573	-119.031	-83.609
2021-09-30	66.219	-105.266	-72.082
2021-06-30	66.42	-100.244	-64.208

CTMX's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• CTMX has a Quality Grade of D, ranking ahead of 22.16% of graded US stocks.
• CTMX's asset turnover comes in at 0.169 -- ranking 210th of 682 Pharmaceutical Products stocks.
• JNJ, LEXX, and ORGS are the stocks whose asset turnover ratios are most correlated with CTMX.

The table below shows CTMX's key quality metrics over time.